China Drug Price Negotiations: Another Race To The Bottom？
Competition, Coverage and Cost Control
With the fourth quarter just around the corner, China's closely-watched annual drug reimbursement and prices negotiations are entering a key final stage. But will applicants need to be more strategic than expedient?
